title: Role of epigenomics in ovarian and endometrial cancers.
abstract: Ovarian cancer is the most lethal gynecologic malignancy and while constituting only 3% of all female cancers, it causes 14,600 deaths in the USA annually. Endometrial cancer, the most diagnosed and second-most fatal gynecologic cancer, afflicts over 40,000 US women annually, causing an estimated 7780 deaths in 2009. In both advanced ovarian and endometrial carcinomas, the majority of initially therapy-responsive tumors eventually evolve to a fully drug-resistant phenotype. In addition to genetic mutations, epigenetic anomalies are frequent in both gynecologic malignancies, including aberrant DNA methylation, atypical histone modifications and dysregulated expression of distinct microRNAs, resulting in altered gene-expression patterns favoring cell survival. In this article, we summarize the most recent hypotheses regarding the role of epigenetics in ovarian and endometrial cancers, including a possible role in tumor 'stemness' and also evaluate the possible therapeutic benefits of reversal of these oncogenic chromatin aberrations.
authors: Medical Sciences Program, Department of Cellular & Integrative Physiology, Indiana University School of Medicine, Jordan Hall 302, 1001 East Third Street, Bloomington, IN 47408, USA.
authors: Curtis
authors: C
authors: Balch
authors: Daniela E
authors: DE
authors: Matei
authors: Tim H-M
authors: TH
authors: Huang
authors: Kenneth P
authors: KP
authors: Nephew
mesh_terms: D014408:Biomarkers, Tumor / Q000378:metabolism; D019175:DNA Methylation / Q000502:physiology*; D019008:Drug Resistance, Neoplasm / Q000235:genetics / Q000502:physiology*; D016889:Endometrial Neoplasms / Q000378:metabolism / Q000503:physiopathology*; D057890:Epigenomics; D005260:Female; D015972:Gene Expression Regulation, Neoplastic / Q000235:genetics / Q000502:physiology*; D006657:Histones / Q000378:metabolism*; D006801:Humans; D035683:MicroRNAs / Q000235:genetics / Q000502:physiology; D010051:Ovarian Neoplasms / Q000378:metabolism / Q000503:physiopathology*
chemical_list: D014408:Biomarkers, Tumor; D006657:Histones; D035683:MicroRNAs